B · Normal
On September 15th, Eli Lilly stated that its oral weight loss drug Foundayo has accounted for more than 30% of new patients in the U.S. oral obesity treatment market since its launch in the United States in April.
weight loss pills 🕐 2026-09-15 20:57

Related telegraphs

Comments

0/500
Captcha (click to refresh)
No comments yet